Protection against malaria in mice is induced by blood stage- arresting histamine-releasing factor (HRF)-deficient parasites

Journal of Experimental Medicine

Volumn 213, Issue 8, 2016, Pages 1419-1428

  Demarta Gatsi, Claudia ^a   Smith, Leanna ^a   Thiberge, Sabine ^b   Peronet, Roger ^a   Commere, Pierre Henri ^c   Matondo, Mariette ^d   Apetoh, Lionel ^f   Bruhns, Pierre ^e   Ménard, Robert ^b   Mécheri, Salaheddine ^a  

^a CNRS   (France)

^b Unité de Biologie et Génétique du Paludisme   (France)

^c Imagopole   (France)

^d Spectrométrie de Masse Structurale et Protéomique   (France)

^e INSERM   (France)

^f UNIVERSITÉ BOURGOGNE FRANCHE COMTÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; FC RECEPTOR; HISTAMINE RELEASING FACTOR; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G2C ANTIBODY; INTERLEUKIN 6; MESSENGER RNA; PROTOZOAL PROTEIN; RNA 18S; UNCLASSIFIED DRUG; IMMUNOGLOBULIN G; INTERLEUKIN-6, MOUSE; PROTOZOON ANTIBODY; TUMOR MARKER; TUMOR PROTEIN, TRANSLATIONALLY-CONTROLLED 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; GENE MUTATION; HOUSEKEEPING GENE; IMMUNE RESPONSE; MALARIA; MOUSE; NEUTROPHIL; NONHUMAN; OPSONIZATION; PARASITE DEVELOPMENT; PARASITEMIA; PHAGOCYTE; PHAGOCYTOSIS; PLASMODIUM BERGHEI; PRIORITY JOURNAL; T LYMPHOCYTE; ANIMAL; DISEASE MODEL; GENETICS; IMMUNOLOGY;

ANIMALS; ANTIBODIES, PROTOZOAN; B-LYMPHOCYTES; BIOMARKERS, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN G; INTERLEUKIN-6; MALARIA; MICE; NEUTROPHILS; PHAGOCYTOSIS; PLASMODIUM BERGHEI; PROTOZOAN PROTEINS; T-LYMPHOCYTES;

EID: 84982902901     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20151976     Document Type: Article

References (24)

1. Alaro, J.R., A. Partridge, K. Miura, A. Diouf, A.M. Lopez, E. Angov, C.A. Long, and J.M. Burns Jr. 2013. A chimeric Plasmodium falciparum merozoite surface protein vaccine induces high titers of parasite growth inhibitory antibodies. Infect. Immun. 81:3843-3854. http://dx.doi.org/10.1128/IAI.00522-13
2. Aly, A.S., M.J. Downie, C.B. Mamoun, and S.H. Kappe. 2010. Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice. Cell. Microbiol. 12:930-938. http://dx.doi.org/10.1111/j.1462-5822.2010.01441.x
3. Barton, B.E. 1997. IL-6: insights into novel biological activities. Clin. Immunol. Immunopathol. 85:16-20. http://dx.doi.org/10.1006/clin.1997.4420
4. Beghdadi, W., A. Porcherie, B.S. Schneider, D. Dubayle, R. Peronet, M. Huerre, T. Watanabe, H. Ohtsu, J. Louis, and S. Mécheri. 2008. Inhibition of histamine-mediated signaling confers significant protection against severe malaria in mouse models of disease. J. Exp. Med. 205:395-408. http://dx.doi.org/10.1084/jem.20071548
5. Bhisutthibhan, J., M.A. Philbert, H. Fujioka, M. Aikawa, and S.R. Meshnick. 1999. The Plasmodium falciparum translationally controlled tumor protein: subcellular localization and calcium binding. Eur. J. Cell Biol. 78:665-670. http://dx.doi.org/10.1016/S0171-9335(99)80052-1
6. Bodescot, M., O. Silvie, A. Siau, P. Refour, P. Pino, J.F. Franetich, L. Hannoun, R. Sauerwein, and D. Mazier. 2004. Transcription status of vaccine candidate genes of Plasmodium falciparum during the hepatic phase of its life cycle. Parasitol. Res. 92:449-452. http://dx.doi.org/10.1007/s00436-003-1061-9
7. Coutelier, J.P., J.T. van der Logt, F.W. Heessen, G. Warnier, and J. Van Snick. 1987. IgG2a restriction of murine antibodies elicited by viral infections. J. Exp. Med. 165:64-69. http://dx.doi.org/10.1084/jem.165.1.64
8. de Koning-Ward, T.F., D.A. Fidock, V. Thathy, R. Menard, R.M. van Spaendonk, A.P. Waters, and C.J. Janse. 2000. The selectable marker human dihydrofolate reductase enables sequential genetic manipulation of the Plasmodium berghei genome. Mol. Biochem. Parasitol. 106:199-212. http://dx.doi.org/10.1016/S0166-6851(99)00189-9
9. Janse, C.J., J. Ramesar, and A.P. Waters. 2006. High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei. Nat. Protoc. 1:346-356. http://dx.doi.org/10.1038/nprot.2006.53
10. + T cells by exogenous cell-associated antigens. Immunity. 17:211-220. http://dx.doi.org/10.1016/S1074-7613(02)00365-5
11. Kishimoto, T., S. Akira, and T. Taga. 1992. Interleukin-6 and its receptor: a paradigm for cytokines. Science. 258:593-597. http://dx.doi.org/10.1126/science.1411569
12. Mathieu, C., C. Demarta-Gatsi, A. Porcherie, S. Brega, S. Thiberge, K. Ronce, L. Smith, R. Peronet, R. Amino, R. Ménard, and S. Mécheri. 2015. Plasmodium berghei histamine-releasing factor favours liver-stage development via inhibition of IL-6 production and associates with a severe outcome of disease. Cell. Microbiol. 17:542-558. http://dx.doi.org/10.1111/cmi.12382
13. Miyagami, T., I. Igarshi, and M. Suzuki. 1987. Plasmodium berghei: long lasting immunity induced by a permanent attenuated mutant. Zentralbl. Bakteriol. Mikrobiol. Hyg. [A]. 264:502-512.
14. Ndungu, F.M., E.T. Cadman, J. Coulcher, E. Nduati, E. Couper, D.W. Macdonald, D. Ng, and J. Langhorne. 2009. Functional memory B cells and long-lived plasma cells are generated after a single Plasmodium chabaudi infection in mice. PLoS Pathog. 5:e1000690. http://dx.doi.org/10.1371/journal.ppat.1000690
15. Nimmerjahn, F., and J.V. Ravetch. 2005. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science. 310:1510-1512. http://dx.doi.org/10.1126/science.1118948
16. Pied, S., L. Rénia, A. Nüssler, F. Miltgen, and D. Mazier. 1991. Inhibitory activity of IL-6 on malaria hepatic stages. Parasite Immunol. 13:211-217. http://dx.doi.org/10.1111/j.1365-3024.1991.tb00276.x
17. Pombo, D.J., G. Lawrence, C. Hirunpetcharat, C. Rzepczyk, M. Bryden, N. Cloonan, K. Anderson, Y. Mahakunkijcharoen, L.B. Martin, D. Wilson, et al. 2002. Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet. 360:610-617. http://dx.doi.org/10.1016/S0140-6736(02)09784-2
18. Puga, I., M. Cols, C.M. Barra, B. He, L. Cassis, M. Gentile, L. Comerma, A. Chorny, M. Shan, W. Xu, et al. 2012. B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat. Immunol. 13:170-180. http://dx.doi.org/10.1038/ni.2194
19. Putrianti, E.D., A. Schmidt-Christensen, I. Arnold, V.T. Heussler, K. Matuschewski, and O. Silvie. 2010. The Plasmodium serine-type SERA proteases display distinct expression patterns and non-essential in vivo roles during life cycle progression of the malaria parasite. Cell. Microbiol. 12:725-739. http://dx.doi.org/10.1111/j.1462-5822.2009.01419.x
20. Spaccapelo, R., C.J. Janse, S. Caterbi, B. Franke-Fayard, J.A. Bonilla, L.M. Syphard, M. Di Cristina, T. Dottorini, A. Savarino, A. Cassone, et al. 2010. Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria. Am. J. Pathol. 176:205-217. http://dx.doi.org/10.2353/ajpath.2010.090504
21. Spaccapelo, R., E. Aime, S. Caterbi, P. Arcidiacono, B. Capuccini, M. Di Cristina, T. Dottorini, M. Rende, F. Bistoni, and A. Crisanti. 2011. Disruption of plasmepsin-4 and merozoites surface protein-7 genes in Plasmodium berghei induces combined virulence-attenuated phenotype. Sci. Rep. 1:39. http://dx.doi.org/10.1038/srep00039
22. Ting, L.M., M. Gissot, A. Coppi, P. Sinnis, and K. Kim. 2008. Attenuated Plasmodium yoelii lacking purine nucleoside phosphorylase confer protective immunity. Nat. Med. 14:954-958. http://dx.doi.org/10.1038/nm.1867
23. Waki, S., J. Tamura, M. Imanaka, S. Ishikawa, and M. Suzuki. 1982. Plasmodium berghei: isolation and maintenance of an irradiation attenuated strain in the nude mouse. Exp. Parasitol. 53:335-340. http://dx.doi.org/10.1016/0014-4894(82)90076-5
24. Wykes, M.N., Y.H. Zhou, X.Q. Liu, and M.F. Good. 2005. Plasmodium yoelii can ablate vaccine-induced long-term protection in mice. J. Immunol. 175:2510-2516. http://dx.doi.org/10.4049/jimmunol.175.4.2510